[Pharmacokinetics of a new highly effective hypoglycemic sulfonylurea derivative].
D000042:Absorption; D000273:Adipose Tissue / Q000032:analysis; D000328:Adult; D000818:Animals; D001646:Bile / Q000032:analysis; D002247:Carbon Isotopes; D004285:Dogs; D005243:Feces / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D007328:Insulin / Q000097:blood; D007668:Kidney / Q000032:analysis; D007700:Kinetics; D008099:Liver / Q000032:analysis; D008297:Male; D009132:Muscles / Q000032:analysis; D010179:Pancreas / Q000032:analysis; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014508:Urea / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use
D002247:Carbon Isotopes; D007004:Hypoglycemic Agents; D007328:Insulin; D014508:Urea